Fludarabine-exposure predicts disease control following CD19-specific car t cell (tisagenlecleucel); a report from pediatric real-world car consortium.
Saved in:
| Title: | Fludarabine-exposure predicts disease control following CD19-specific car t cell (tisagenlecleucel); a report from pediatric real-world car consortium. |
|---|---|
| Authors: | Curran, K.J.1,2 (AUTHOR), Fabrizio, V.A.1,2 (AUTHOR), Mauguen, A.1 (AUTHOR), Boelens, J.J.3 (AUTHOR), Baggott, C.4 (AUTHOR), Prabhu, S.4 (AUTHOR), Placenta, H.5 (AUTHOR), Phillips, C.L.6 (AUTHOR), Rossoff, J.7 (AUTHOR), Stefanski, H.8 (AUTHOR), Talano, J.9 (AUTHOR), Moskop, A.9 (AUTHOR), Margossian, S.P.10,11 (AUTHOR), Verneris, M.R.12 (AUTHOR), Myers, G.13 (AUTHOR), Karras, N.A.14 (AUTHOR), Brown, P.A.15 (AUTHOR), Qayed, M.16 (AUTHOR), Hermiston, M.17 (AUTHOR), Satwani, P.18 (AUTHOR) |
| Source: | Cytotherapy (Elsevier Inc.). 2021 Supplement, Vol. 23 Issue 5, pS27-S27. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
